GRI Bio Participates in a Virtual Investor CEO Connect Segment
Access the CEO Connect segment here LA JOLLA, CA, March 18, 2025 (GLOBE…
Pierre Fabre Laboratories and RedRidge Bio Announce a Drug Discovery and Co-development Partnership
CASTRES, France, CAMBRIDGE, Massachusetts and BASEL, Switzerland, March 12, 2025 /PRNewswire/ --…
Tevogen Bio Founder and CEO Dr. Ryan Saadi Named to 2025 NJBIZ Power 100, Celebrating Innovation and Leadership in Accessible T Cell Therapy
Tevogen Bio is focused on delivering affordable, safe, and easy-to-administer T cell…
Intelligent Bio Solutions Inc. Announces Closing of $3.0 Million Public Offering of Common Stock and Full Exercise of the Underwriters Option to Purchase Additional Shares of Common Stock
February 21, 2025 16:05 ET | Source: Intelligent Bio Solutions, Inc. NEW…
Tevogen Bio CEO Reinforces Commitment to Retention of Equity Capital and Long-Term Vision
WARREN, N.J., Feb. 14, 2025 (GLOBE NEWSWIRE) -- Ryan Saadi, MD, MPH,…
Tevogen Bio CEO Addresses Short Selling and Its Potential Impact on the Nations Health and Prosperity
WARREN, N.J., Feb. 14, 2025 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen Bio…
Bio X Cell Expands Global Reach with New Distribution Center in Beijing, China
LEBANON, N.H., Feb. 11, 2025 /PRNewswire/ -- Bio X Cell, the world's…
Belite Bio Announces Registered Direct Offering of $15 Million
February 05, 2025 22:35 ET | Source: Belite Bio, Inc SAN DIEGO,…
Boundless Bio Appoints Robert Doebele, M.D., Ph.D., as Chief Medical Officer
- Dr. Doebele has over 15 years of oncology drug development experience…
Annovis Bio, Inc. Announces Proposed Public Offering
MALVERN, Pa., Jan. 31, 2025 (GLOBE NEWSWIRE) -- via IBN – Annovis…